🇺🇸 FDA
Patent

US 7928129

Nanomolar β-lactamase inhibitors

granted A61KA61K31/38A61K31/425

Quick answer

US patent 7928129 (Nanomolar β-lactamase inhibitors) held by Northwestern University expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/38, A61K31/425